ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Magnesium: Widespread Deficiency with Deadly Consequences

Gut Bacteria, Artificial Sweeteners and Glucose Intolerance

Reverse Mitochondrial Damage

Strengthening DNA to Prevent Inflammation, Heart Disease, Dementia and More

Culprits of Autism Identified: Toxins, Gut Bacteria, Nutritional Deficiencies, and Vaccines Made wit...

CoQ10: The Longevity Factor

Turmeric compound boosts regeneration of brain stem cells

Use of Broad-Spectrum Antibiotics Before Age 2 Associated with Obesity Risk

Extending Life and Fighting Disease with Resveratrol

Is Homocysteine Making You Sick?

 
Print Page
Email Article

Melatonin-Based Compound Judged an Advance in Depression Therapy

  [ 18 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 1, 2011


“Agomelatine is currently approved in the EU, US and Australia, and represents a significant step forward in the approach to the treatment of depression and other mood disorders."

Agomelatine, a unique chemical variation on melatonin, emerged the winner in a recent depression therapy investigation at two Australian research centers.

The investigation – which focused on comparing the effects of melatonin and several melatonin ‘analogue’ compounds – suggested that agomelatine shows particular promise as an advance in antidepressant therapy for two reasons.

• It provides levels of antidepressant activity similar to those of some widely used depression drugs.

• And, like the nutrient melatonin which is known for its ability to support regulation of the body’s internal sleep-wake clock (circadian system), agomelatine improves the sleep-wake patterns of those treated.

The investigation of melatonin and its relatives, reported online May 18 by the Lancet (“Novel melatonin-based therapies: Potential advances in the treatment of major depression”) was a natural step forward for mental health research, the authors say.

“Although available drugs are effective, they also have substantial limitations. Recent advances in our understanding of the fundamental links between chronobiology and major mood disorders, as well as the development of new drugs that target the circadian system, have led to a renewed focus on this area," say researchers Ian B Hickie, at the University of Sydney’s Brain & Mind Research Institute, and Naomi L Rogers, at Central Queensland University.

The paper says there is clear evidence that there are strong links between circadian disturbance and some of the most characteristic symptoms of clinical depression, including delayed sleep onset, non-restful sleep, early-morning wakening, daytime fatigue, and blunting or reversal of the normal morning peaks in subjective energy, mood, and alertness.

Most patients with depression have prolonged sleep latencies and a high frequency of arousals and awakenings during the night, Hickie and Rogers note. Consequently, sleepiness, daytime fatigue, or napping might be prominent.

Comparing Melatonin and Its Sister Compounds

Although melatonin and its sister compounds bind to the same receptor sites in the brain, they have a different affinity for these sites, the authors explain.

So they compared melatonin, ramelteon, tasimelteon, PD-6735, and agomelatine - and found agomeltatine to be the analogue with the most potential to help depressed patients.

They believe the antidepressant effects of agomelatine may be due to its unique combination of binding to melatonin receptors and blocking serotonin receptors in the brain.

• "In the short-term, agomelatine has similar antidepressant efficacy to venlafaxine, fluoxetine, and sertraline,”

• "And, in the longer term, fewer patients on agomelatine relapse (24%) than do those receiving placebo (50%).

• "Patients with depression treated with agomelatine report improved sleep quality and reduced waking after sleep onset."

Less Potential for Side Effects

They conclude: "As agomelatine does not raise serotonin levels, it has less potential for the common gastrointestinal, sexual, or metabolic side-effects that characterise many other antidepressant compounds...

“Because of its favorable adverse effect and safety profile, and the potential to help to restore circadian function between depressive episodes, this drug might occupy a unique place in the management of some patients with severe depression and other major mood disorders."

They conclude that “Agomelatine is currently approved in the EU, US and Australia, and represents a significant step forward in the approach to the treatment of depression and other mood disorders."

Source: The Lancet news release, May 17, 2011, excerpted.



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

VIDEO: Healthy Eating and Fibromyalgia VIDEO: Healthy Eating and Fibromyalgia
Broad Spectrum Protection Against Brain Aging Broad Spectrum Protection Against Brain Aging
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Live Longer: Groundbreaking Research on Omega-3s Live Longer: Groundbreaking Research on Omega-3s

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing